The 72 references in paper P. Nyrkova A., N. Savenkova D., П. Ныркова А., Н. Савенкова Д. (2015) “Исследования эффективности цитостатической терапии часто рецидивирующего, гормонозависимого и со стероидной токсичностью нефротического синдрома у детей // Studies of cytostatic therapy efficiency for frequently relapsing steroid dependent nephrotic syndrome with steroid toxicity in children” / spz:neicon:nefr:y:2015:i:1:p:30-40

1
International Study of Kidney Disease in Children. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 1981; 98 (4): 561-564 Таблица 7 Преимущества и недостатки цитостатических препаратов, используемых при часто рецидивирующем гормонозависимом нефротическом синдроме у детей (KDIGO Clinical Practice Guideline for Glomerulonephritis, 2012) [72] ПрепаратПреимуществаНедостатки Циклофосфамид -Длительная ремиссия после лечения -Дешевизна -Менее эффективен при гормонозависимом НС -Необходим мониторинг анализа крови в течение лечения -Потенциальные серьезные немедленные и отдаленные побочные эффекты -Возможно проведение только одного курса Хлорамбутин-Длительная ремиссия посл
(check this in PDF content)
2
APN Arbeitsgemeinschaft fur PadiatrischeNephrologie Short versus standart prednisolone therapy for initial treatment of idiopatic nephrotic syndrome in children. Lancet 1988;1: 380-383
(check this in PDF content)
3
Гринбаум НБ. Особенности нефротического синдрома у детей. В: Гломерулонефрит. Под ред. С.И. Рябова.- Л. 1980: 164-176 [Greenbaum NB. Osobennosti nefroticheskogo sindroma u detei`. V Glomerulonefrit. Pod red. S.I. Riabova.- L. 1980: 164-176]
(check this in PDF content)
4
Gbadegesin R, Smoyer W. Nephrotic Syndrome. In Comprehensive Pediatric Nephrology. Editors D. Geary, F. Schaefer. MOSBY. 2008; 205-218
(check this in PDF content)
5
Hodson E, Alecsander S, and Graf N. Steroid-Sensitive Nephrotic Syndrome.In Comprehensive Pediatric Nephrology. Editors D.Geary, F. Schaefer. MOSBY 2008; 239-256
(check this in PDF content)
6
Arbeitsgemeinschaft fur PadiatrischeNephrologie: Minimal -change nephrotic syndrome (MCNS): long prednisone versus standard prednisone therapy (Abst) PediatrNephrol 1990; 4 :60
(check this in PDF content)
7
Niauted P. Steroid-Sensitive IdiopaticNephrotic Syndrome in Children.In Pediatric Nephrology. Editors E.Avner, W.Harmon, P.Niauted. LIPPINCOTT-WILLIAMS-WILKINS, 2004: 544-556
(check this in PDF content)
8
Niauted P, Boyer O. Idiopathic Nephrotic Syndrome in Children: Clinical Aspects. In Pediatric Nephrology, 6- th edition. Editors E. Avner, W.Harmon, N Yoshikawa.IPNA. Springer-Verlag, 2009; Vol.1:667-702
(check this in PDF content)
9
Brodehl J. Conventional therapy for idiopathic nephrotic syndrome in children. Clin. Nephrol1991; 35(1): 8-15
(check this in PDF content)
10
Савенкова НД, Папаян АВ. Нефротический синдром в практике педиатра. С-Пб., Эскулап (1999): 256 [Savenkova ND, Papajan AV. Nefroticheskij sindrom v praktike pediatra. S-Pb., Jeskulap (1999): 256]
(check this in PDF content)
11
Батракова ИВ, Савенкова НД. Цитостатическая терапия нефротического синдрома с минимальными изменениями у детей. Нефрология 2004; 2:98-105 [Batrakova IV, Savenkova ND. Citostaticheskaja terapija nefroticheskogo sindroma s minimal’nymi izmenenijami u detej. Nefrologija 2004; 2:98-105]
(check this in PDF content)
12
Савенкова НД, Папаян АВ, Батракова ИВ. Нефротический синдром с минимальными изменениями у детей. В: Клиническая нефрология детского возраста. «Левша. Санкт-Петербург», 2008; 279-302 [Savenkova ND, Papajan AV, Batrakova IV. Nefroticheskij sindrom s minimal’nymi izmenenijami u detej. V Klinicheskaja nefrologija detskogo vozrasta. «Levsha. Sankt-Peterburg», 2008; 279-302]
(check this in PDF content)
13
Bargman JM. Management of minimal lesion glomerulonephritis Evidence-based recommendations. Kidney Int 1999; Suppl 70 (55): 3-16
(check this in PDF content)
14
Савенкова НД. Стратегия терапии дебюта, рецидивирующего и часто рецидивирующего гормоночувствительного и гормонозависимого нефротического синдрома с минимальными изменениями у детей. Нефрология 2013 No3: 17-25 [Savenkova ND. Strategija terapii debjuta, recidivirujushhego i chasto recidivirujushhego gormonochuvstvitel’nogo i gormonozavisimogo nefroticheskogo sindroma s minimal’nymi izmenenijami u detej. Nefrologija 2013 No3: 17-25]
(check this in PDF content)
15
Lombel RM, Hodson EM, Gipson DS. Treatment of steroidresistant nephritic syndrome in children: new guidelines from KDIGO. Pediatr Nephrol 2013 Mar;28(3):409-414
(check this in PDF content)
16
Clark A, Barratt TM. Steroid-responsive nephrotic syndrome. InPediatric nephrology. Edited by Т.М. Barratt, E.D. Avner, WE Harman. LIPPINCOTT-WILLIAMS-WILKINS, 1998; 731-747
(check this in PDF content)
17
Pennisi AJ, Grushkin CM, Lieberman E. Cyclophosphamid in the treatment of idiopathic nephrotic syndrome. Pediatrics1976; 57: 948-951
(check this in PDF content)
18
International Study of Kidney Disease in Children: Prospective, controlled trial of cyclophosphamide therapy in children with the nephrotic syndrome. Lancet 1974; 2: 423-427
(check this in PDF content)
19
Arbeitsgemeinschaft fur Padiatrische Nephrologie: Cyclophosphamide treatment of steroid dependent nephrotic syndrome: Comparison of eight week with 12 week course. Arch Dis Child 1987; 62: 1102-1106
(check this in PDF content)
20
Ueda N, Kuno K, Ito S. Eight and 12 week courses of cyclophosphamide in nephrotic syndrome. Arch Dis Child 1990; 85: 1147-1150
(check this in PDF content)
21
Ponticelli C, Edefonti A, Ghio L.Cyclosporin versus cyclophosphamide for patients with steroid dependent and frequently relapsing idiopathic nephrotic syndrome: a multicenter randomized controlled trial. Nephrol Dial Transplant 1993; 8: 1326–1332
(check this in PDF content)
22
Takeda A, Niimura F. Long-term effect of immunosuppressants in steroid-dependent nephrotic syndrome. PediatrNephrol 1998; 12 (9): 746-750
(check this in PDF content)
23
Kemper MJ, Altrogg H, Ludwig K et al. Unfavorable response to cyclophosphamide in steroid-dependent nephrotic syndrome. PediatrNephrol 2000; 14: 772-775
(check this in PDF content)
24
Vester U, Zimmermann S, Hoyer P. Cyclophosphamide therapy in frequent relapsing and steroid dependent minimal change nephrotic syndrome: new insights from an old protocol (abstract). PediatrNephrol 1999; 13: 67
(check this in PDF content)
25
Vester U, Kranz B, Zimmermann S, Hoyer P. Cyclophosphamide in frequently relapsing and steroid dependent nephrotic syndrome: Abstracts The 12 the Congress of the International Pediatric. NephrologyAssociationPediatrNephrol 2001; 16 (8): 258
(check this in PDF content)
26
Vester U, Kranz B. Cyclophosphamide in steroid-sensitive nephrotic syndrome outcome and outlook. PediatrNephrol.(2003) 18: 661-664
(check this in PDF content)
27
Kyrieleis HA, Levtcenko EN, Wetzels JF. Long-term outcome after cyclophosphamide treatment in children with steroiddependent and frequently relapsing minimal change nephritic syndrome.Am J Kidney Dis 2007; 49:592-597
(check this in PDF content)
28
Sümegi V, Haszon I, Bereczki C, Papp F, Túri S. Long-term follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and -resistant nephrotic syndrome. PediatrNephrol 2008 Jul;23(7):1085-1092
(check this in PDF content)
29
Chen SY, Wu CY, Tsai IJ, Tsau YK. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect. Nephrology (Carlton) 2010;15(3):336-339
(check this in PDF content)
30
Cammas B, Harambat J, Bertholet-Thomas A. et al. Longterm effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome. Nephrol Dial Transplantant 2011; 26: 178-184
(check this in PDF content)
31
Zagury A, Louse A. et al. Long- term follow-up after cyclophosphamide therapy in steroid dependent nephrotic syndrome. Pediatr Nephro l2011; 26: 915-920
(check this in PDF content)
32
Azib S, Macher M, Kwon T et al. Cyclophosphamide in steroid dependent nephrotic syndrome. Pediatr Nephrol 2011; 26: 927-932
(check this in PDF content)
33
Grup W, Makker SP, Ingelfinger JR. Chlorambucil treatment of frequently relapsing nephrotic syndrome. N Engl J Med 1976; 295: 746-749
(check this in PDF content)
34
Niaudet P. Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology. PediatrNephrol 1992;6(1):1-3
(check this in PDF content)
35
Настаушева ТЛ, Ситникова ВП, Стеньшинская EB, Cтaxурлова ЛИ. Иммуносупрессивная терапия гломерулонефрита у детей цитостатическими препаратами алкилирующего действия. Нефрология и диализ 2000 2(4): 291-292 [Nastausheva TL, Sitnikova VP, Sten’shinskaja EB, Ctaxurlova LI. Immunosupressivnaja terapijaglomerulonefrita u detej citostaticheskimi preparatami alkilirujushhego dejstvija. Nefrologija i dializ 2000 2(4): 291-292]
(check this in PDF content)
36
Lewis MA, Baildom EM, Davis N, Houston IB, Postlethwaite RJ. Nephrotic syndrome: from toddlers to twenties. Lancet 1989 Feb 4;1(8632):255-259
(check this in PDF content)
37
Fakhouri F, Bocquet N, Taupin P. et al. Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis 2003 Mar;41(3):550-7
(check this in PDF content)
38
Rüth EM, Kemper MJ, Leumann EP. Et al. Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome. J Pediatr 2005 Aug;147(2):202-7
(check this in PDF content)
39
Kyrieleis H, Löwik M, Pronk I. et al. Clin Long-Term Outcome of Biopsy-Proven, Frequently Relapsing Minimal-Change Nephrotic Syndrome in Children. J Am SocNephrol 2009; 4(10): 1593–1600
(check this in PDF content)
40
Kitano Y, Yoshikawa N, Tanaka R et al. Cyclosporin treatment in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 1990; 4: 474-477
(check this in PDF content)
41
Tanaka Н, Yoshikava N, Kitano Y: Long-term Cyclosporin treatment in children with steroid dependent nephrotic syndrome. Pediatr Nephrol 1993; 7: 249-252
(check this in PDF content)
42
Ponticelli C, Edefonti A, Ghio L. et al Cyclosporin versus cyclophosphamide for patients with steroid dependent and frequently relapsing idiopathic nephrotic syndrome: a multicenter randomized controlled trial. Nephrol Dial Transplant 1993; 8: 1326–1332
(check this in PDF content)
43
Hulton SA, Neuhaus TJ, Dillon MJ, Barrat TM. Long-term cyclosporine A treatment of minimal-change nephrotic syndrome of children. Pediatr Nephrol 1994; 8: 401-403
(check this in PDF content)
44
Inou Y, Iijima K, Nakamura H, Yoshikava N: Two-year Cyclosporin treatment in children with steroid dependent nephrotic syndrome. Pediatr Nephrol 1999; 13: 33-38
(check this in PDF content)
45
Игнатова МС, Турпитко ОЮ, Харина ЕА, Обухова ВА. Результаты многоцентрового изучения эффективности циклоспорина А при нефротическом синдроме у детей. Педиатрия 2008; 87:93-97 [Ignatova MS, Turpitko OJu, Harina EA, Obuhova VA. Rezul’taty mnogocentrovogo izuchenija jeffektivnosti ciklosporina A pri nefroticheskom sindrome u detej. Pediatrija 2008; 87:93-97]
(check this in PDF content)
46
Dorresteijn EM, Kist-van Holthe JE, Levtchenko EN, Nauta J, Hop WC, van der Heijden AJ. Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome. Pediatr Nephrol 2008; 23(11):2013–2020
(check this in PDF content)
47
Wang W, Xia Y,Mao J. et al. Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome. Pediatr Nephrol 2012; 27: 2073-2079
(check this in PDF content)
48
Tejani A, Butt K,TrechtmanH. Cyclosporin A induced remission of frequently relapsing nephrotic syndrome in children. Kidney Int1988; 33:729-734
(check this in PDF content)
49
Iijima K, Hamahira K, Tanaka R. et al. Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney Int 2002; 61(5):1801-1805
(check this in PDF content)
50
Rinaldi S, Sesto A, Barsotti P et al. Cyclosporine therapy monitored with abbreviated area under curve in nephrotic syndrome. Pediatr Nephrol 2005; 20: 25-29
(check this in PDF content)
51
Matsumoto H, Hakao T, Okada T et al. Initial remission inducing effect of very low-olosecyclosporin monotherapy for minimal-change nephrotic syndrome in Japannese adults. Clin. Nephrol2001; 55(2): 143-148
(check this in PDF content)
52
Fujinaga S, Kaneko K, Muto T. et al. Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome. Arch Dis Child 2006; 91(8):666-670
(check this in PDF content)
53
Igarashi Y et al. Steroid-sparing effect of mizoribine in long-term nephrotic syndrome of children. PediatrNephrol 1994; 8: 396-397
(check this in PDF content)
54
Yoshioka K, Ohashi Y, Sacai T et al. A multicenter trial of mizoribine compared with placebo in children in frequently relapsing idiopathic nephrotic syndrome. Kidney Int 2000; 58: 317-324
(check this in PDF content)
55
Fujieda M, Ishihara M, Morita T. et al. Effect of oral mizoribine pulse therapy for frequently relapsing steroid-dependent nephrotic syndrome. ClinNephrol 2008; 69(3):179-184
(check this in PDF content)
56
Fujieda M, Ishihara M, Morita T. et al. Effect of singledose oral mizoribine pulse therapy twice per week for frequently relapsing steroid-dependent nephrotic syndrome. Clin Nephrol 2012;78(1):40-46
(check this in PDF content)
57
Fujinaga S, Hirano D, Nishizaki N. Single daily high-dose mizoribine therapy for children with steroid-dependent nephritic syndrome prior to cyclosporine administration. Pediatr Nephrol 2011; 26: 479-483
(check this in PDF content)
58
Kawasaki Y, Takano K, Isome M et al. Efficacy of single dose of oral mizoribine pulse therapy two times per week for frequently relapsing nephritic syndrome. J Nephrol 2007 20:52-56
(check this in PDF content)
59
Hogg R, Fizgibbons L, Bruick J et al. Multicenter trial of mycophenolate mofetil (MMF) in children with steroid dependent (SD) or frequently relapsing (FR) nephrotic syndrome (NS). Report of the southwest pediatric nephrology study group. Abstract book from the World Congress of Nephrology.June 8-12, Berlin (2003). Nephrol Dial Transplant 2003; 18 (Suppl. 4): 261
(check this in PDF content)
60
Barletta GM, Smoyer WE, BunchmannTE et al. Use of mycophenolate mofetil in steroid-dependent and-resistant nephrotic syndrome. Pediatr Nephrol 2003; 18:833-837
(check this in PDF content)
61
Vallejo GG, Liern MM, De Reyes VV et al. Enteric Coated Mycophenolate Sodium in Patients with steroid-dependent nephrotic syndrome. Congress Abstracts the 15th Congress of the International Pediatric Nephrology Association. August 29- September2, 2010, New York. Pediatr Nephrol 2010; 25:1886
(check this in PDF content)
62
Bagga A, Hari P, Moudgil A, Jordan SC: Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephritic syndrome. Am J Kidney Dis 2003;42: 1114–1120
(check this in PDF content)
63
Novak L, Frank R, Vento S et al. Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol 2005; 20(9) 1265-1268
(check this in PDF content)
64
Mendizabal S, Zamona I, Berbel O et al. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome. Pediatr Nephrol 2005; 20(7):914-919
(check this in PDF content)
65
Kwinta-Rybicka J, Wilkosz K, Wierchowska-Slowiacze EK et al. Mycophenolate mofetil in treatment of childhood nephrotic syndrome –preliminary report. Przegl Lec 2006;63 Suppl 3:44-48
(check this in PDF content)
66
Fujinaga S, Ohtomo Y, Umino D. et al. A prospective study on the use of mycophenolate mofetil in children with cyclosporinedependent nephrotic syndrome. Pediatr Nephrol 2007; 22: 71–76
(check this in PDF content)
67
Afzal K, Bagga A, Menon S et al. Treatment with mycophenolatemofetil and prednisolone for steroid-dependent nephritic syndrome. Pediatr Nephrol 2007; 22: 2059–2065
(check this in PDF content)
68
Nickavar A, Safarzadeh AE, Sotoudeh K et al. Mycophenolate mofetil for treatment of idiopathic nephrotic syndrome in children. Iran J Kidney Dis 2012; 6(5):346-349
(check this in PDF content)
69
Baudouin V, Albrti C, Lapeyraque AL et al. Mycophenolate mofetil for steroid-dependent nephrotic syndrome: a phase II Bayesian trial. Pediatr Nephrol 2012;27(3):389-396
(check this in PDF content)
70
Banerjee S, Pahari A, Sengupta J, Patnaik S. Outcome of severe steroid-dependent nephrotic syndrome treated with mycophenolate mofetil. Pediatr Nephrol 2013; 28:93-97
(check this in PDF content)
71
Gellermann J, Weber L, Pape L. et al. Mycofenolate Mofetil versus Cyclosporin A in children with frequently relapsing nephrotic syndrome. J Am Soc Nephrol 2013; 24(10):1689-1697
(check this in PDF content)
72
Lombel RM, Gipson DS, Hodson EM. Treatment of steroidsensitive nephrotic syndrome: new guidelines from KDIGO. Pediatr Nephrol 2013 Mar;28(3):415-426 Авторы заявляют об отсутствии конфликта интересов.
(check this in PDF content)